Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), a specialty pharmaceutical company, is focusing their efforts on addressing cancer and other unmet medical needs. With headquarters in Irvine, California, the company employs approximately 65 employees that meticulously strive to bring new drugs through clinical development and regulatory approval. Spectrum’s staff is devoted to promoting excellence and aims to make a difference every day. For further information, visit the Company’s web site at www.spectrumpharm.com.
- 18 years ago
QualityStocks
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…